vs
PREFORMED LINE PRODUCTS CO（PLPC）与PTC THERAPEUTICS, INC.（PTCT）财务数据对比。点击上方公司名可切换其他公司
PREFORMED LINE PRODUCTS CO的季度营收约是PTC THERAPEUTICS, INC.的1.1倍（$173.1M vs $164.7M），PREFORMED LINE PRODUCTS CO净利率更高（4.9% vs -82.0%，领先86.8%），PREFORMED LINE PRODUCTS CO同比增速更快（3.6% vs -22.7%），PREFORMED LINE PRODUCTS CO自由现金流更多（$11.8M vs $-36.6M），过去两年PREFORMED LINE PRODUCTS CO的营收复合增速更高（10.8% vs -11.5%）
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
PLPC vs PTCT — 直观对比
营收规模更大
PLPC
是对方的1.1倍
$164.7M
营收增速更快
PLPC
高出26.3%
-22.7%
净利率更高
PLPC
高出86.8%
-82.0%
自由现金流更多
PLPC
多$48.4M
$-36.6M
两年增速更快
PLPC
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $173.1M | $164.7M |
| 净利润 | $8.4M | $-135.0M |
| 毛利率 | 29.8% | — |
| 营业利润率 | 6.8% | -43.3% |
| 净利率 | 4.9% | -82.0% |
| 营收同比 | 3.6% | -22.7% |
| 净利润同比 | -19.3% | -104.8% |
| 每股收益（稀释后） | $1.72 | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLPCPTCT
| Q4 25 | $173.1M | $164.7M | ||
| Q3 25 | $178.1M | $211.0M | ||
| Q2 25 | $169.6M | $178.9M | ||
| Q1 25 | $148.5M | $1.2B | ||
| Q4 24 | $167.1M | $213.2M | ||
| Q3 24 | $147.0M | $196.8M | ||
| Q2 24 | $138.7M | $186.7M | ||
| Q1 24 | $140.9M | $210.1M |
净利润PLPCPTCT
| Q4 25 | $8.4M | $-135.0M | ||
| Q3 25 | $2.6M | $15.9M | ||
| Q2 25 | $12.7M | $-64.8M | ||
| Q1 25 | $11.5M | $866.6M | ||
| Q4 24 | $10.5M | $-65.9M | ||
| Q3 24 | $7.7M | $-106.7M | ||
| Q2 24 | $9.4M | $-99.2M | ||
| Q1 24 | $9.6M | $-91.6M |
毛利率PLPCPTCT
| Q4 25 | 29.8% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 32.7% | — | ||
| Q1 25 | 32.8% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 31.1% | — | ||
| Q2 24 | 31.9% | — | ||
| Q1 24 | 31.3% | — |
营业利润率PLPCPTCT
| Q4 25 | 6.8% | -43.3% | ||
| Q3 25 | 7.4% | 1.4% | ||
| Q2 25 | 10.1% | -19.5% | ||
| Q1 25 | 8.8% | 82.5% | ||
| Q4 24 | 10.5% | -76.2% | ||
| Q3 24 | 7.1% | -27.7% | ||
| Q2 24 | 8.1% | -21.5% | ||
| Q1 24 | 8.2% | -21.6% |
净利率PLPCPTCT
| Q4 25 | 4.9% | -82.0% | ||
| Q3 25 | 1.5% | 7.5% | ||
| Q2 25 | 7.5% | -36.3% | ||
| Q1 25 | 7.8% | 73.7% | ||
| Q4 24 | 6.3% | -30.9% | ||
| Q3 24 | 5.2% | -54.2% | ||
| Q2 24 | 6.8% | -53.1% | ||
| Q1 24 | 6.8% | -43.6% |
每股收益（稀释后）PLPCPTCT
| Q4 25 | $1.72 | $-1.63 | ||
| Q3 25 | $0.53 | $0.20 | ||
| Q2 25 | $2.56 | $-0.83 | ||
| Q1 25 | $2.33 | $10.04 | ||
| Q4 24 | $2.13 | $-0.85 | ||
| Q3 24 | $1.54 | $-1.39 | ||
| Q2 24 | $1.89 | $-1.29 | ||
| Q1 24 | $1.94 | $-1.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.9B |
| 总债务越低越好 | $38.3M | — |
| 股东权益账面价值 | $475.5M | $-205.3M |
| 总资产 | $653.6M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资PLPCPTCT
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $884.8M |
总债务PLPCPTCT
| Q4 25 | $38.3M | — | ||
| Q3 25 | $36.0M | — | ||
| Q2 25 | $31.8M | — | ||
| Q1 25 | $29.1M | — | ||
| Q4 24 | $20.8M | — | ||
| Q3 24 | $27.2M | — | ||
| Q2 24 | $31.6M | — | ||
| Q1 24 | $55.0M | — |
股东权益PLPCPTCT
| Q4 25 | $475.5M | $-205.3M | ||
| Q3 25 | $466.3M | $-155.8M | ||
| Q2 25 | $460.7M | $-206.5M | ||
| Q1 25 | $435.8M | $-185.8M | ||
| Q4 24 | $422.3M | $-1.1B | ||
| Q3 24 | $429.0M | $-1.1B | ||
| Q2 24 | $416.2M | $-980.2M | ||
| Q1 24 | $413.4M | $-893.9M |
总资产PLPCPTCT
| Q4 25 | $653.6M | $2.9B | ||
| Q3 25 | $644.6M | $2.6B | ||
| Q2 25 | $631.5M | $2.6B | ||
| Q1 25 | $592.5M | $2.7B | ||
| Q4 24 | $573.9M | $1.7B | ||
| Q3 24 | $592.0M | $1.8B | ||
| Q2 24 | $572.6M | $1.9B | ||
| Q1 24 | $586.1M | $1.8B |
负债/权益比PLPCPTCT
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.08× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.08× | — | ||
| Q1 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.9M | $-34.3M |
| 自由现金流经营现金流 - 资本支出 | $11.8M | $-36.6M |
| 自由现金流率自由现金流/营收 | 6.8% | -22.3% |
| 资本支出强度资本支出/营收 | 5.9% | 1.4% |
| 现金转化率经营现金流/净利润 | 2.60× | — |
| 过去12个月自由现金流最近4个季度 | $33.3M | $702.3M |
8季度趋势，按日历期对齐
经营现金流PLPCPTCT
| Q4 25 | $21.9M | $-34.3M | ||
| Q3 25 | $18.9M | $-66.3M | ||
| Q2 25 | $26.9M | $-58.3M | ||
| Q1 25 | $5.7M | $870.1M | ||
| Q4 24 | $24.1M | $-30.0M | ||
| Q3 24 | $9.4M | $-77.0M | ||
| Q2 24 | $28.3M | $-71.5M | ||
| Q1 24 | $5.8M | $70.8M |
自由现金流PLPCPTCT
| Q4 25 | $11.8M | $-36.6M | ||
| Q3 25 | $8.3M | $-69.7M | ||
| Q2 25 | $18.6M | $-59.6M | ||
| Q1 25 | $-5.3M | $868.4M | ||
| Q4 24 | $20.6M | $-33.8M | ||
| Q3 24 | $5.8M | $-77.5M | ||
| Q2 24 | $24.6M | $-78.8M | ||
| Q1 24 | $1.8M | $61.2M |
自由现金流率PLPCPTCT
| Q4 25 | 6.8% | -22.3% | ||
| Q3 25 | 4.7% | -33.1% | ||
| Q2 25 | 10.9% | -33.3% | ||
| Q1 25 | -3.6% | 73.8% | ||
| Q4 24 | 12.3% | -15.8% | ||
| Q3 24 | 3.9% | -39.4% | ||
| Q2 24 | 17.7% | -42.2% | ||
| Q1 24 | 1.3% | 29.1% |
资本支出强度PLPCPTCT
| Q4 25 | 5.9% | 1.4% | ||
| Q3 25 | 6.0% | 1.6% | ||
| Q2 25 | 4.9% | 0.7% | ||
| Q1 25 | 7.4% | 0.1% | ||
| Q4 24 | 2.1% | 1.8% | ||
| Q3 24 | 2.4% | 0.3% | ||
| Q2 24 | 2.7% | 4.0% | ||
| Q1 24 | 2.8% | 4.6% |
现金转化率PLPCPTCT
| Q4 25 | 2.60× | — | ||
| Q3 25 | 7.21× | -4.17× | ||
| Q2 25 | 2.12× | — | ||
| Q1 25 | 0.49× | 1.00× | ||
| Q4 24 | 2.30× | — | ||
| Q3 24 | 1.22× | — | ||
| Q2 24 | 3.02× | — | ||
| Q1 24 | 0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
